136 related articles for article (PubMed ID: 26854442)
21. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
[TBL] [Abstract][Full Text] [Related]
22. Serum heat shock protein 70 and its correlation with clinical characteristics in patients with sudden sensorineural hearing loss.
Park SN; Yeo SW; Park KH
Laryngoscope; 2006 Jan; 116(1):121-5. PubMed ID: 16481823
[TBL] [Abstract][Full Text] [Related]
23. Serum Expression of
Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
[TBL] [Abstract][Full Text] [Related]
24. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
[TBL] [Abstract][Full Text] [Related]
25. Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.
Li Q; Wang K; Su C; Fang J
Technol Cancer Res Treat; 2017 Aug; 16(4):440-445. PubMed ID: 27760866
[TBL] [Abstract][Full Text] [Related]
26. Association between serum angiopoietin-2 concentration and clinicopathological parameters in patients with colorectal cancer.
Wang ZQ; Sun XL; Su HL; Liu XF; Xuan YJ; Yu SQ
Genet Mol Res; 2015 Dec; 14(4):15547-52. PubMed ID: 26634521
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
[TBL] [Abstract][Full Text] [Related]
28. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
29. Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia.
Fukushima A; Kawahara H; Isurugi C; Syoji T; Oyama R; Sugiyama T; Horiuchi S
J Obstet Gynaecol Res; 2005 Feb; 31(1):72-7. PubMed ID: 15669997
[TBL] [Abstract][Full Text] [Related]
30. The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
Rašić I; Rašić A; Akšamija G; Radović S; Šehović N
Med Glas (Zenica); 2017 Aug; 14(2):229-235. PubMed ID: 28644426
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic yield of heat shock protein 70 (HSP-70) and anti-HSP-70 in Behcet-induced uveitis.
Sahebari M; Hashemzadeh K; Mahmoudi M; Saremi Z; Mirfeizi Z
Scand J Immunol; 2013 Jun; 77(6):476-81. PubMed ID: 23701436
[TBL] [Abstract][Full Text] [Related]
32. HSP70 as a Diagnostic and Prognostic Marker in Egyptian Women With Breast Cancer.
Fahim HH; Mohamed G; Safwat G; Abo-Bakr A; Ibraheem MH; Al-Mofty S; Kamel MM; Abdel-Moneim AS; Gameel AM
Clin Breast Cancer; 2021 Jun; 21(3):e177-e188. PubMed ID: 33323333
[TBL] [Abstract][Full Text] [Related]
33. Serum HSP70: a novel biomarker for early detection of pancreatic cancer.
Dutta SK; Girotra M; Singla M; Dutta A; Otis Stephen F; Nair PP; Merchant NB
Pancreas; 2012 May; 41(4):530-4. PubMed ID: 22158074
[TBL] [Abstract][Full Text] [Related]
34. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
[TBL] [Abstract][Full Text] [Related]
35. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
36. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study.
Molvarec A; Prohászka Z; Nagy B; Szalay J; Füst G; Karádi I; Rigó J
J Hum Hypertens; 2006 Oct; 20(10):780-6. PubMed ID: 16761027
[TBL] [Abstract][Full Text] [Related]
37. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein70: a new marker for subsequent atrial fibrillation development?
Oc M; Ucar HI; Pinar A; Akbulut B; Oc B; Akyon Y; Kanbak M; Dogan R
Artif Organs; 2008 Nov; 32(11):846-50. PubMed ID: 18959676
[TBL] [Abstract][Full Text] [Related]
39. Is Serum Caveolin-1 a Useful Biomarker for Progression in Patients with Colorectal Cancer?
Erdemli HK; Kocabas R; Salis O; Sen F; Akyol S; Eskin F; Akyol O; Bedir A; Sahin AF
Clin Lab; 2016; 62(3):401-8. PubMed ID: 27156330
[TBL] [Abstract][Full Text] [Related]
40. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
Otero-Estévez O; De Chiara L; Rodríguez-Girondo M; Rodríguez-Berrocal FJ; Cubiella J; Castro I; Hernández V; Martínez-Zorzano VS
Sci Rep; 2015 Aug; 5():13030. PubMed ID: 26264519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
